[Effect of bencyclan and theophylline on changes of platelet aggregation and factor 3 activity].
The ADP- and adrenaline-induced platelet aggregation and platelet factor 3 availability were studied in patients before and eight hours after intravenous administration of bencyclan (100 mg) and/or theophylline (240 mg). Aggregation was primarily inhibited by bencyclan, the availability of factor 3 was inhibited by theophylline. Combination of both drugs exerted additive effects on both parameters. The combined use of drugs as inhibitors of aggregation is recommended, since they inhibit primary haemostasis simultaneously at two points of attack.
D001537:Bencyclane / Q000494:pharmacology*; D003508:Cycloheptanes / Q000494:pharmacology*; D004357:Drug Synergism; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D013806:Theophylline / Q000494:pharmacology*; D013925:Thromboplastin
D003508:Cycloheptanes; D001537:Bencyclane; D013925:Thromboplastin; D013806:Theophylline
Die Veränderungen der Thrombozytenaggregation und Faktor-3-Aktivität unter der Wirkung von Bencyclan und Theophyllin.